contract_awardAwarded Thursday, May 21, 2026Analyzed

EMERGENT, LLC: $70.6M Department of Veterans Affairs Contract

Neutral

Summary

EMERGENT, LLC, a private entity, secured a $70.6M delivery order from the Department of Veterans Affairs for an Oracle enterprise license agreement. Because the recipient is private, this contract cannot be attributed to any publicly traded company, though it signals continued federal investment in healthcare IT infrastructure.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.No publicly traded company directly benefits from this contract, as EMERGENT, LLC is private.
  • 2.The award confirms ongoing VA investment in enterprise software, a neutral signal for health IT spending broadly.
  • 3.Retail investors should avoid speculating on public tickers based on this contract alone.

Market Implications

This contract has no direct market implications for publicly traded equities. Investors should treat it as a data point on VA IT spending trends but not as a catalyst for any specific ticker. The absence of a public parent company means no revenue impact can be reliably modeled for listed firms. If Oracle Corporation ($ORCL) is a licensor, the amount is far below 0.1% of its $50B+ annual revenue and not reportable.

Full Analysis

This $70.6M contract award to EMERGENT, LLC by the Department of Veterans Affairs is an Oracle enterprise license agreement, structured as a delivery order. The recipient is a private limited liability company with no publicly traded parent or recognized subsidiary, per EDGAR records. Therefore, no direct mapping to public equities is possible. The contract covers a period from May 2026 to April 2027, indicating a one-year enterprise software licensing arrangement. From a sector perspective, this award underscores ongoing federal spending on healthcare technology modernization, particularly within the VA, which manages one of the largest healthcare systems in the U.S. Several healthcare-related bills in the database, such as HR8875 (Improving Home Dialysis Act) and HR8324 (Great American Healthcare Plan), could create tailwinds for broader health IT spending, but they are not directly linked to this specific contract. Without a public beneficiary, the market implications are indirect: Oracle Corporation ($ORCL) may see a minor downstream benefit if its licensing revenue includes this deal through a reseller, but the contract's structure prevents reliable attribution. Similarly, IT services firms that partner with the VA, like Booz Allen Hamilton ($BAH) or Science Applications International Corp ($SAIC), could see analogous opportunities, but this specific award does not tie to them. Historically, federal IT contracts of this size tend to be routine renewals rather than market-moving events. The $70.6M is modest in the context of the $100B+ federal IT market. No historical pattern of stock price inflection from such VA software license renewals exists without a public recipient. Supply chain analysis is not actionable here because EMERGENT, LLC's subcontractor relationships are not publicly disclosed, and guessing would produce false positives.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderMay 19, 2026

Integrating Financial Technology Innovation into Regulatory Frameworks

This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

Contract Details

Recipient

EMERGENT, LLC

Award Amount

$70,607,910

Awarding Agency

Department of Veterans Affairs

Sub-Agency

Department of Veterans Affairs

Contract Type

DELIVERY ORDER